PHASE-II EVALUATION OF MENOGARIL IN PATIENTS WITH ADVANCED CERVICAL-CARCINOMA - A COLLABORATIVE TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP AND MAYO-CLINIC

被引：0
|
作者：
LONG, HJ
WIEAND, HS
FOLEY, JF
NIEDRINGHAUS, RD
LAURIE, JA
MORTON, RF
GOLDBERG, RM
MAILLIARD, JA
MALKASIAN, GD
EDMONSON, JH
机构：
[1] MAYO CLIN & MAYO FDN,CTR CANC,STAT UNIT,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT OBSTET & GYNECOL,ROCHESTER,MN 55905
[3] CREIGHTON UNIV,NEBRASKA ONCOL GRP,OMAHA,NE 68178
[4] UNIV NEBRASKA,MED CTR,OMAHA,NE 68105
[5] DULUTH CLIN CCOP,DULUTH,MN 55805
[6] GRAND FORKS CLIN LTD,GRAND FORKS,ND 58201
[7] IOWA ONCOL RES ASSOC CCOP,DES MOINES,IA 50314
[8] GEISINGER CLIN & MED CTR CCOP,DANVILLE,PA 17822
来源：
INVESTIGATIONAL NEW DRUGS | 1991年 / 9卷 / 04期
关键词：
MENOGARIL; CERVIX CANCER; SQUAMOUS CELL CARCINOMA; PHASE-II TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Fourteen patients with advanced/recurrent squamous cell carcinoma of the uterine cervix received menogaril, 200 mg/m2 by one hour intravenous infusion at four-week intervals. No objective regressions were observed. Median time to progression was less than two months and median survival was seven months. All patients experienced neutropenia. Platelet toxicity was negligible. Venous irritation and phlebitis occurred at the infusion site in 43% of patients. Menogaril as administered in this protocol is ineffective in treating previously irradiated advanced/recurrent squamous cell carcinoma of the uterine cervix and warrants no further investigation in this disease at the dosage and administration schedule used in this protocol.
引用
收藏
页码：349 / 351
页数：3
相关论文
共 50 条
  • [1] A PHASE-II EVALUATION OF MENOGARIL IN CISPLATIN-REFRACTORY ADVANCED OVARIAN-CARCINOMA - A COLLABORATIVE TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP AND THE MAYO-CLINIC
    LONG, HJ
    LAURIE, JA
    WIEAND, HS
    EDMONSON, JH
    LEVITT, R
    KROOK, JE
    ABUGHAZALEH, S
    CANCER, 1991, 68 (04) : 730 - 732
  • [2] ALLEVIATION OF CANCER ANOREXIA AND CACHEXIA - STUDIES OF THE MAYO-CLINIC AND THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP
    LOPRINZI, CL
    ELLISON, NM
    GOLDBERG, RM
    MICHALAK, JC
    BURCH, PA
    SEMINARS IN ONCOLOGY, 1990, 17 (06) : 8 - 12
  • [3] EVALUATION OF THE CONTINUOUS INFUSION OF ETOPOSIDE PLUS CISPLATIN IN METASTATIC BREAST-CANCER - A COLLABORATIVE NORTH CENTRAL CANCER-TREATMENT GROUP MAYO-CLINIC PHASE-II STUDY
    KROOK, JE
    LOPRINZI, CL
    SCHAID, DJ
    KARDINAL, CG
    MAILLIARD, JA
    PFEIFLE, DM
    ELLISON, NM
    REUTER, NF
    NELIMARK, RA
    CANCER, 1990, 65 (03) : 418 - 421
  • [4] RANDOMIZED PHASE-II STUDIES IN ADVANCED COLORECTAL-CARCINOMA - A NORTH-CENTRAL-CANCER-TREATMENT-GROUP STUDY
    WINDSCHITL, H
    SCOTT, M
    SCHUTT, A
    MCCORMACK, G
    EVERSON, L
    CULLINAN, S
    GERSTNER, J
    KROOK, J
    LAURIE, J
    SHRECK, R
    MARSCHKE, R
    DELPFEIFLE
    CANCER TREATMENT REPORTS, 1983, 67 (11): : 1001 - 1008
  • [5] A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP
    GESME, DH
    JETT, JR
    SCHREFFLER, DD
    SU, JQ
    MAILLIARD, JA
    FOLEY, JF
    KROOK, JE
    MAKSYMIUK, AW
    HATFIELD, AK
    EBBERT, LP
    PFEIFLE, DM
    MORTON, RF
    TSCHETTER, LK
    SCHAEFER, PL
    CANCER, 1993, 71 (09) : 2723 - 2726
  • [6] RANDOMIZED TRIAL OF BILATERAL OOPHORECTOMY (OX) VERSUS TAMOXIFEN (TAM) IN PREMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER - A COLLABORATIVE TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP AND MAYO-CLINIC
    INGLE, JN
    KROOK, JE
    GREEN, SJ
    KUBISTA, TP
    AHMANN, DL
    EVERSON, LK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 163 - 163
  • [7] PHASE-II STUDY OF VM-26 AND VP-16 IN RECURRENT PRIMARY BRAIN-TUMOR - A COLLABORATIVE TRIAL OF NORTH CENTRAL CANCER-TREATMENT GROUP AND MAYO-CLINIC
    CASCINO, T
    DINAPOLI, R
    KROOK, J
    OFALLON, J
    EVERSON, L
    MARSCHKE, R
    CULLINAN, S
    NEUROLOGY, 1986, 36 (04) : 336 - 336
  • [8] RADICAL IRRADIATION AND MISONIDAZOLE IN THE TREATMENT OF ADVANCED CERVICAL-CARCINOMA - RESULTS OF A PHASE-II TRIAL
    GIRINSKI, T
    PEJOVIC, MH
    HAIE, C
    BONNAY, M
    GERBAULET, A
    MAZERON, JJ
    MALAISE, E
    CHASSAGNE, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (10): : 1783 - 1787
  • [9] A DOUBLE-BLIND TRIAL OF TAMOXIFEN PLUS PREDNISOLONE VERSUS TAMOXIFEN PLUS PLACEBO IN POSTMENOPAUSAL WOMEN WITH METASTATIC BREAST-CANCER - A COLLABORATIVE TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP AND MAYO-CLINIC
    INGLE, JN
    MAILLIARD, JA
    SCHAID, DJ
    KROOK, JE
    GESME, DH
    WINDSCHITL, HE
    PFEIFLE, DM
    ETZELL, PS
    GERSTNER, JG
    LONG, HJ
    FOLEY, JF
    LOPRINZI, CL
    DALTON, RJ
    CANCER, 1991, 68 (01) : 34 - 39
  • [10] PHASE-II TRIAL OF MENOGARIL IN PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA - AN ILLINOIS CANCER COUNCIL TRIAL
    LOCKER, GY
    KILTON, L
    HOELTGEN, T
    KNOP, RH
    BENSON, AB
    CHERNICOFF, D
    BARRETT, J
    BLOUGH, R
    JOHNSON, C
    CANCER TREATMENT REPORTS, 1987, 71 (09): : 871 - 872
12345